KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Non Operating Income (2016 - 2022)

Biogen (BIIB) has 14 years of Non Operating Income data on record, last reported at -$263.3 million in Q1 2022.

  • For Q1 2022, Non Operating Income rose 48.06% year-over-year to -$263.3 million; the TTM value through Mar 2022 reached -$215.3 million, down 16461.54%, while the annual FY2025 figure was -$305.6 million, 11.06% up from the prior year.
  • Non Operating Income reached -$263.3 million in Q1 2022 per BIIB's latest filing, up from -$506.9 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $683.5 million in Q4 2020 and bottomed at -$506.9 million in Q1 2021.
  • Average Non Operating Income over 5 years is -$10.1 million, with a median of -$37.8 million recorded in 2018.
  • Peak YoY movement for Non Operating Income: crashed 472.17% in 2019, then soared 1486.41% in 2020.
  • A 5-year view of Non Operating Income shows it stood at -$28.6 million in 2018, then tumbled by 72.38% to -$49.3 million in 2019, then skyrocketed by 1486.41% to $683.5 million in 2020, then tumbled by 174.16% to -$506.9 million in 2021, then soared by 48.06% to -$263.3 million in 2022.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were -$263.3 million in Q1 2022, -$506.9 million in Q1 2021, and $683.5 million in Q4 2020.